Jones Financial Companies
DFTX

Jones Financial Companies’s Definium Therapeutics DFTX Stock Holding History

Jones Financial Companies’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.22K Buy
+180
New +$3.06K ﹤0.01% 4007

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jones Financial Companies's DFTX Position: Q1 2026 in Review

Jones Financial Companies opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 180 shares worth $3.22K. The stake represents ﹤0.01% of the portfolio and ranks #4007 among its holdings.

247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Jones Financial Companies held 180 shares of Definium Therapeutics worth $3.22K as of Q1 2026.
  • Definium Therapeutics was a new Jones Financial Companies position in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4007 holding.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.